Showing results (1991-2000 of 14,097) with videos related to

Sort By:
Pageof 1,410
Gynecologic Oncology|December 17, 2019
Predictors of survival trajectories among women with epithelial ovarian cancerLauren C Peres, Sweta Sinha, Mary K Townsend, et al.
Gynecologic Oncology|December 17, 2019
Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancerV Balaya, A Bresset, B Guani, et al.
Gynecologic Oncology|December 25, 2019
EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low grade ovarian cancerRebecca C Arend, Allison M Davis, Przemyslaw Chimiczewski, et al.
Gynecologic Oncology|December 25, 2019
Current status of therapeutic HPV vaccinesKatharine T Clark, Cornelia L Trimble
Gynecologic Oncology|February 25, 2020
The risk of developing squamous cell carcinoma in patients with anogenital lichen sclerosis: A systematic reviewJudith J Spekreijse, Bianca M M Streng, Ravi F M Vermeulen, et al.
Gynecologic Oncology|March 11, 2020
Retroperitoneal lymph node recurrence of epithelial ovarian cancer: Prognostic factors and treatment outcomeT Levy, Z Migdan, N Aleohin, et al.
Gynecologic Oncology|March 12, 2020
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A lossDouglas I Lin, Amanda Hemmerich, Claire Edgerly, et al.
Gynecologic Oncology|March 7, 2020
Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapyHakyoung Kim, Won Kyung Cho, Yeon Joo Kim, et al.
Gynecologic Oncology|March 7, 2020
An integrated molecular profile of endometrioid ovarian cancerWilliam E Pierson, Pamela N Peters, Matthew T Chang, et al.
Gynecologic Oncology|March 16, 2020
Reasons for guideline non-adherence in older and younger women with advanced stage ovarian cancerI C van Walree, R Bretveld, L H van Huis-Tanja, et al.
Pageof 1,410